U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363590) titled 'A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)' on Jan. 16.
Brief Summary: This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).
Study Start Date: Feb. 06
Study Type: INTERVENTIONAL
Condition:
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Intervention:
BIOLOGICAL: MK-1045
IV infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Merck Sharp & Dohme LLC
Published by HT Digital Conte...